141 related articles for article (PubMed ID: 36602591)
21. Tramadol-induced hypoglycemia: A pharmacovigilance study.
De Canecaude C; Rousseau V; Sommet A; Montastruc JL
Fundam Clin Pharmacol; 2021 Oct; 35(5):933-936. PubMed ID: 33511683
[TBL] [Abstract][Full Text] [Related]
22. Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.
Pugi A; Bonaiuti R; Maggini V; Moschini M; Tuccori M; Leone R; Rossi M; Motola D; Piccinni C; Ferrazin F; Sottosanti L; Mugelli A; Vannacci A; Lapi F
Am J Health Syst Pharm; 2013 Jun; 70(12):1039-46. PubMed ID: 23719881
[TBL] [Abstract][Full Text] [Related]
23. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.
Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
[TBL] [Abstract][Full Text] [Related]
24. Associations between osteoporosis and drug exposure: A post-marketing study of the World Health Organization pharmacovigilance database (VigiBase®).
Batteux B; Bennis Y; Bodeau S; Masmoudi K; Hurtel-Lemaire AS; Kamel S; Gras-Champel V; Liabeuf S
Bone; 2021 Dec; 153():116137. PubMed ID: 34343739
[TBL] [Abstract][Full Text] [Related]
25. Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports.
Wakao R; Taavola H; Sandberg L; Iwasa E; Soejima S; Chandler R; Norén GN
Drug Saf; 2019 Dec; 42(12):1487-1498. PubMed ID: 31559542
[TBL] [Abstract][Full Text] [Related]
26. Aromatase inhibitors associated osteonecrosis of jaw: signal refining to identify pseudo safety signals.
Neha R; Beulah E; Anusha B; Vasista S; Stephy C; Subeesh V
Int J Clin Pharm; 2020 Apr; 42(2):721-727. PubMed ID: 32270377
[TBL] [Abstract][Full Text] [Related]
27. Cardiac failure in patients treated with azacitidine, a pyrimidine analogue: Case reports and disproportionality analyses in Vigibase.
Perino J; Mottal N; Bohbot Y; Servant V; Berroneau A; Poustis P; Fenaux P; Laribi K; Charbonnier A; Bilion E; Calmettes C; Bégaud B; Pigneux A; Milpied N; Miremont-Salamé G; Théophile H; Dimicoli-Salazar S
Br J Clin Pharmacol; 2020 May; 86(5):991-998. PubMed ID: 31912911
[TBL] [Abstract][Full Text] [Related]
28. Statin-induced myasthenia: A disproportionality analysis of the WHO's VigiBase pharmacovigilance database.
Gras-Champel V; Batteux B; Masmoudi K; Liabeuf S
Muscle Nerve; 2019 Oct; 60(4):382-386. PubMed ID: 31298743
[TBL] [Abstract][Full Text] [Related]
29. Ocular Safety Profile of BRAF and MEK Inhibitors: Data from the World Health Organization Pharmacovigilance Database.
Mettler C; Monnet D; Kramkimel N; Tréluyer JM; Mouthon L; Brézin A; Dupin N; Valnet-Rabier MB; Chouchana L; Terrier B
Ophthalmology; 2021 Dec; 128(12):1748-1755. PubMed ID: 34000304
[TBL] [Abstract][Full Text] [Related]
30. Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database.
Noseda R; Bedussi F; Gobbi C; Zecca C; Ceschi A
Cephalalgia; 2021 Jun; 41(7):789-798. PubMed ID: 33435709
[TBL] [Abstract][Full Text] [Related]
31. Reports of sexual disorders related to serotonin reuptake inhibitors in the French pharmacovigilance database: an example of underreporting.
Trenque T; Maura G; Herlem E; Vallet C; Sole E; Auriche P; Drame M
Drug Saf; 2013 Jul; 36(7):515-9. PubMed ID: 23728950
[TBL] [Abstract][Full Text] [Related]
32. Pharmacovigilance in ophthalmology in Switzerland: an analysis of the most frequently reported ocular adverse drug reactions within the last 25 years.
Karrer JE; Giovannoni L; Kullak-Ublick GA; Weiler S
Swiss Med Wkly; 2019 Jun; 149():w20085. PubMed ID: 31256417
[TBL] [Abstract][Full Text] [Related]
33. Finasteride Use Is Associated with Higher Odds of Obstructive Sleep Apnea: Results from the US Food and Drug Administration Adverse Events Reporting System.
Gupta MA; Vujcic B; Gupta AK
Skinmed; 2020; 18(3):146-150. PubMed ID: 32790610
[TBL] [Abstract][Full Text] [Related]
34. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting.
Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M
Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028
[TBL] [Abstract][Full Text] [Related]
35. SGLT2 inhibitors associated pancreatitis: signal identification through disproportionality analysis of spontaneous reports and review of case reports.
Palapra H; Viswam SK; Kalaiselvan V; Undela K
Int J Clin Pharm; 2022 Dec; 44(6):1425-1433. PubMed ID: 36224513
[TBL] [Abstract][Full Text] [Related]
36. Adverse event profiles of drugs used for treatment of juvenile idiopathic arthritis according to spontaneous reporting system database.
Niinomi I; Oyama S; Inada A; Wakabayashi T; Hirai T; Kambara H; Iida T; Uchida M; Sano Y; Hosohata K
Int J Clin Pharmacol Ther; 2022 Sep; 60(9):402-407. PubMed ID: 35924642
[TBL] [Abstract][Full Text] [Related]
37. Drug-induced depressive symptoms: An update through the WHO pharmacovigilance database.
Li J; Zelmat Y; Storck W; Laforgue EJ; Yrondi A; Balcerac A; Sommet A; Montastruc F
J Affect Disord; 2024 Apr; 350():452-467. PubMed ID: 38244800
[TBL] [Abstract][Full Text] [Related]
38. Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system.
Chen JJ; Huo XC; Wang SX; Wang F; Zhao Q
Int J Clin Pharm; 2022 Dec; 44(6):1351-1360. PubMed ID: 36178607
[TBL] [Abstract][Full Text] [Related]
39. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias.
Pariente A; Gregoire F; Fourrier-Reglat A; Haramburu F; Moore N
Drug Saf; 2007; 30(10):891-8. PubMed ID: 17867726
[TBL] [Abstract][Full Text] [Related]
40. Pharmacovigilance Assessment of Drug-Induced Acute Pancreatitis Using a Spontaneous Reporting Database.
Niinomi I; Hosohata K; Oyama S; Inada A; Wakabayashi T; Iwanaga K
Int J Toxicol; 2019; 38(6):487-492. PubMed ID: 31470743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
